6.78 USD
-0.72 (-9.6%)
ChartMill assigns a Buy % Consensus number of 83% to NSRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.91. This target is 208.41% above the current price.
NSRX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NSRX.
In the previous month the buy percentage consensus was at a similar level.
NSRX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-18 | Citizens | Initiate | Market Outperform |
| 2025-09-29 | Laidlaw & Co. | Initiate | Buy |
NASUS PHARMA LTD / NSRX FAQ
What is the average price target for NASUS PHARMA LTD (NSRX) stock?
7 analysts have analysed NSRX and the average price target is 20.91 USD. This implies a price increase of 208.41% is expected in the next year compared to the current price of 6.78.
Can you provide the consensus rating for NASUS PHARMA LTD stock?
The consensus rating for NASUS PHARMA LTD (NSRX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for NSRX stock?
The number of analysts covering NASUS PHARMA LTD (NSRX) is 7.